ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

22,185Medicare Part D Prescriptions Filled, Including Refills

Rank: 3 out of 421

$1.2M Total Retail Price of All Prescriptions

Rank: 3 out of 421

934 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
54% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

2% of this provider’s 934 patients filled at least one prescription for a schedule three drug, compared to an average of 1%.

Risky Drugs to Seniors

0% of this provider’s 17,703 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
ISOSORBIDE MONONITRATE ER 2,007 1,603 10 1 11
PRAVASTATIN SODIUM 1,435 1,140 2 12
LISINOPRIL 1,382 1,104 3 2
CLOPIDOGREL 1,359 1,087 10 4 10
CARVEDILOL 1,304 1,021 5 1
BYSTOLIC 1,048 847 10 6 29
FUROSEMIDE 892 658 7 5
PLAVIX 860 712 8 13
LOSARTAN POTASSIUM 747 557 9 16
POTASSIUM CHLORIDE 744 626 10 19
DIGOXIN 676 497 11 14
RANEXA 602 377 12 31
SIMVASTATIN 585 522 13 6
AMLODIPINE BESYLATE 572 463 14 4
WARFARIN SODIUM 498 439 15 7
KLOR-CON M20 404 293 16 27
CRESTOR 369 274 17 15
METOPROLOL TARTRATE 291 262 18 3
EFFIENT 287 212 19 47
HYDROCHLOROTHIAZIDE 246 182 20 18
HYDRALAZINE HCL 232 192 21 21
DIOVAN 221 171 22 23
LOSARTAN-HYDROCHLOROTHIAZIDE 207 192 23 36
ATORVASTATIN CALCIUM 207 135 23 9
FAMOTIDINE 189 128 25 64
PANTOPRAZOLE SODIUM 174 131 26 41
SOTALOL 158 150 27 38
SUCRALFATE 157 126 28 116
TEKTURNA 154 132 29 151
GEMFIBROZIL 152 129 30 93
RAMIPRIL 141 139 31 32
METOPROLOL SUCCINATE 138 101 32 8
ATENOLOL 133 121 33 17
DILTIAZEM 24HR CD 128 91 34 59
LOVAZA 119 94 35 82
FOSINOPRIL SODIUM 119 115 35 133
DIOVAN HCT 114 114 37 52
NITROSTAT 113 92 38 24
FENOFIBRATE 104 72 39 40
CLONIDINE HCL 103 81 40 33
KLOR-CON 10 95 78 41 67
LABETALOL HCL 95 83 41 75
NIFEDIPINE ER 90 74 43 53
BUMETANIDE 87 62 44 77
EXFORGE 87 82 44 114
DILTIAZEM 24HR ER 81 56 46 39
PROPAFENONE HCL 78 66 47 72
KLOR-CON M10 73 60 48 89
BENAZEPRIL HCL 68 62 49 48
PRADAXA 68 30 49 25
TRIAMTERENE-HCTZ 68 58 49 55
FELODIPINE ER 63 60 52 136
LOVASTATIN 61 55 53 49
LISINOPRIL-HYDROCHLOROTHIAZIDE 61 51 53 34
LIPITOR 58 41 55 37
ZETIA 54 43 56 26
DILTIAZEM ER 53 38 57 62
NITROGLYCERIN PATCH 52 45 58 57
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 10, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.